Trial Details

RECRUITING
Basic Information
Clinical ID c1348
Identifier NCT05430412
Trial Title CT to Assess the Efficacy and Safety of Adding GMA to Infliximab in Paediatric Patients With Steroid-refractory Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DEVICE: Adacolumn
Participant Information
Sponsor Adacyte Therapeutics SL
City Coimbra
Country/Region Portugal
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT
Study Design
Study Type INTERVENTIONAL
Phase -
Time Information
Start Date 2022-01-11
Primary Completion Date 2025-10-24
Completion Date 2025-10-24